date,title,source
Oct-26-18,Intellipharmaceutics Regains Compliance with Nasdaq Minimum Shareholders' Equity Listing Requirements,ACCESSWIRE
Nov-05-18,Intellipharmaceutics Announces Resignation of Chief Financial Officer,ACCESSWIRE
Nov-20-18,Intellipharmaceutics Reports Exclusive Distribution Agreements in Malaysia and Vietnam,ACCESSWIRE
Nov-21-18,Intellipharmaceutics Reports Exclusive Supply Agreement for its Abuse-Deterrent Oxycodone ER Product Candidate and Four Generic Drug Products in the Philippines,ACCESSWIRE
Nov-26-18,Intellipharmaceutics Announces Receipt of Nasdaq Notice,ACCESSWIRE
